We are live on ! Find out more
ESPR

Esperion Therapeutics
ESPR

Delisted

ESPR was delisted on the 10th of July, 2026.

152 hedge funds and large institutions have $991M invested in Esperion Therapeutics in 2019 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 49 increasing their positions, 50 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

31% more call options, than puts

Call options by funds: $23.3M | Put options by funds: $17.8M

2% less repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 50

6.2% less ownership

Funds ownership: 105.68%99.48% (-6.2%)

9% less funds holding

Funds holding: 167152 (-15)

25% less capital invested

Capital invested by funds: $1.32B → $991M (-$333M)

50% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 30

Holders
152
Holders Change
-15
Holders Change %
-8.98%
% of All Funds
3.33%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
15
Increased
49
Reduced
50
Closed
30
Calls
$23.3M
Puts
$17.8M
Net Calls
+$5.52M
Net Calls Change
-$13.9M
Name Holding Trade Value Shares
Change
Change in
Stake
Walleye Capital
176
Walleye Capital
New York
-$21K -529 Closed
Twin Tree Management
177
Twin Tree Management
Texas
-$6K -133 Closed
PCP
178
Proficio Capital Partners
Massachusetts
-$1K -19 Closed
WWM
179
Willingdon Wealth Management
North Carolina
+$79 +2 New
GWS
180
Glassman Wealth Services
Virginia
+$277 +7 New
IA
181
IFP Advisors
Florida
+$357 +9 New